Kairos Pharma Ltd — Cash Flow (NYSE:KAPA)

Financials

Cash from operating activities -3.96 M-3.44 M -3.44 M Cash from investing activities —— — Cash from financing activities 5.13 M6.66 M 6.66 M Free cash flow -3.96 M-3.44 M -3.44 M